Zhengye Biotechnology Holding (ZYBT) Cash & Current Investments (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Cash & Current Investments of $7.3 million for Q4 2025, up 162.27% year-over-year from $2.8 million in Q4 2024, and up 11.12% quarter-over-quarter from $6.6 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Cash & Current Investments (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Cash & Current Investments for 3 consecutive years, with $7.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments rose 162.27% year-over-year to $7.3 million; the TTM figure through Dec 2025 stood at $7.3 million (up 162.27% YoY), while the FY2025 annual figure was $7.3 million, up 155.78% from the prior year.
- Cash & Current Investments advanced to $7.3 million in Q4 2025 per ZYBT's latest filing, from $6.6 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $7.3 million in Q4 2025 and bottomed at $2.8 million in Q4 2024.
- Historically, Cash & Current Investments has averaged $5.5 million across 3 years, with a median of $6.0 million in 2023.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 48.89% — and 2025, when it jumped 162.27%.
- Zhengye Biotechnology Holding's Cash & Current Investments stood at $5.5 million in 2023, then slumped by 48.89% to $2.8 million in 2024, then surged by 162.27% to $7.3 million in 2025.
- Business Quant data shows ZYBT's Cash & Current Investments at $7.3 million in Q4 2025, $6.6 million in Q2 2025, and $2.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | Zhengye Biotechnology Holding | 88.82 Mn | 81.50 Mn | - | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.32 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Dec 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | 5.46 Mn |